GB1235540A - Oral preparations containing proteolytic enzymes suitable for pediatric use - Google Patents

Oral preparations containing proteolytic enzymes suitable for pediatric use

Info

Publication number
GB1235540A
GB1235540A GB5701768A GB5701768A GB1235540A GB 1235540 A GB1235540 A GB 1235540A GB 5701768 A GB5701768 A GB 5701768A GB 5701768 A GB5701768 A GB 5701768A GB 1235540 A GB1235540 A GB 1235540A
Authority
GB
United Kingdom
Prior art keywords
compositions
proteolytic enzymes
preparations containing
oral preparations
enzymes suitable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5701768A
Inventor
Bruno Manzini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armour Pharmaceutical Co
Original Assignee
Armour Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharmaceutical Co filed Critical Armour Pharmaceutical Co
Priority to GB5701768A priority Critical patent/GB1235540A/en
Publication of GB1235540A publication Critical patent/GB1235540A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4826Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,235,540. Medicines containing enzymes. ARMOUR PHARMACEUTICAL CO. 2 Dec., 1968, No. 57017/68. Heading A5B. Orally administrable compositions comprise trypsin and/or chymotrypsin in intimate admixture with powdered skim milk, the preparation having a protein content of not more than 1.0 gram per 50,000 AU of enzyme activity. The compositions may contain flavours and may comprise additional medicaments, e.g. penicillin, chloramphenicol tetracycline hydrochloride, sulphisoxazole or sulphaniloamide, which are readily soluble in a pharmaceutically acceptable solvent especially water. The compositions may be dissolved in pharmaceutical liquid carriers for administration, e.g. as a syrup.
GB5701768A 1968-12-02 1968-12-02 Oral preparations containing proteolytic enzymes suitable for pediatric use Expired GB1235540A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5701768A GB1235540A (en) 1968-12-02 1968-12-02 Oral preparations containing proteolytic enzymes suitable for pediatric use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5701768A GB1235540A (en) 1968-12-02 1968-12-02 Oral preparations containing proteolytic enzymes suitable for pediatric use

Publications (1)

Publication Number Publication Date
GB1235540A true GB1235540A (en) 1971-06-16

Family

ID=10478146

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5701768A Expired GB1235540A (en) 1968-12-02 1968-12-02 Oral preparations containing proteolytic enzymes suitable for pediatric use

Country Status (1)

Country Link
GB (1) GB1235540A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
EP0196434A1 (en) * 1985-03-20 1986-10-08 Societe Des Produits Nestle S.A. Process for the preparation of a composition based on a divided substance with a slight hydrosolubility
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
WO2009068301A1 (en) * 2007-11-30 2009-06-04 Pharmathen S.A Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispersing agent and method for the preparation thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
EP0196434A1 (en) * 1985-03-20 1986-10-08 Societe Des Produits Nestle S.A. Process for the preparation of a composition based on a divided substance with a slight hydrosolubility
CH663899A5 (en) * 1985-03-20 1988-01-29 Nestle Sa PROCESS FOR THE PREPARATION OF A COMPOSITION BASED ON A FINELY DIVIDED LOW HYDROSOLUBILITY ACTIVE INGREDIENT.
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
WO2009068301A1 (en) * 2007-11-30 2009-06-04 Pharmathen S.A Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispersing agent and method for the preparation thereof
US8435982B2 (en) 2007-11-30 2013-05-07 Pharmathen S.A. Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof

Similar Documents

Publication Publication Date Title
GB1161439A (en) Pharmaceutical Compositions
EP0130779A3 (en) Pharmaceutical composition suitable for intestinal administration
GB1198764A (en) A Urate Oxidase and process for the production thereof
GB1235540A (en) Oral preparations containing proteolytic enzymes suitable for pediatric use
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1297221A (en)
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
FR2017318A1 (en) Orally administered pharmaceutical composition - containing an acrylic polymer
GB1353834A (en) Benzenesulphonamides
IE35711L (en) Pharmaceutical compositions
GB1327560A (en) Effervescent pharmaceutical preparations
GB1375806A (en)
NZ219717A (en) Pharmaceutical formulations containing indomethacin, a metabolic carboxylic acid salt and a metabolisable carbohydrate
GB1313318A (en) Pharmaceutical preparation for the treatment of hemorrhoids
GB1182320A (en) Dihydroorotic and Salts
IE34275L (en) Alpha-hydrazino acids
IE33519L (en) Benzylhydrazides
IE36150B1 (en) Iron preparation
GB1392004A (en) Propoxyphene salts
GB861351A (en) Antibiotic compositions and methods of preparing them
GB1251237A (en)
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
CA957941A (en) Pharmaceutical compositions containing 4,7-phenanthroline 5,6 quinone, pancreatin, bromelin and dehydrocholic acid
GB1316006A (en) Pharmaceutically active chemical compound and an antitumourigenic preparation containing same
EP0367509A3 (en) Formulations